GSK
Breathing life into COPD research
March 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COPD, GSK, feature
Alison Hollands, Vice President, Respiratory, UK Pharmaceuticals at GlaxoSmithKline, addresses the importance of implementing the latest approaches to treating COPD …
Monthly injections offer similar efficacy to daily pills in HIV phase 3 trials
March 8, 2019Medical Communications ATLAS, GSK, HIV, ViiV, flair, injectable
A long acting, injectable two drug regimen developed by Pfizer and GSK joint venture ViiV Healthcare and J&J subsidiary Jannsen, …
Top Ten most popular articles on Pharmafile.com this week!
February 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, Merck, Pfizer, falsified medicines, strike, top 10
The strike in Ireland featured twice in this week’s top 10 after Pfizer employees in County Cork lost a dispute …
GSK buys Merck KGaA’s cancer immunotherapy for $4.2 billion
February 6, 2019Research and Development GSK, M7824, Merck, immunotherapy
British multinational GlaxoSmithKline has agreed to pay up to €3.7 billion ($4.2 billion) for the rights to Merck KGaA’s next …
Philip Hampton to step down from chairman role at GSK
January 28, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, UK, appointment, pharma
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
GSK acquires oncology firm Tesaro for $5.1 billion
January 23, 2019Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer
British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …
Philip Hampton to step down from chairman role at GSK
January 21, 2019Sales and Marketing Chairman, GSK, GlaxoSmithKline, appointment, philip hampton
Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …
GSK and Pfizer combine healthcare units in multibillion dollar deal
December 19, 2018Research and Development GSK, OTC, Pfizer, healthcare, merger
American multinational Pfizer and British firm GlaxoSmithKline are set to combine their consumer healthcare units in a venture worth billions. …
The December issue of Pharmafocus is available to read online now!
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma
The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
Working Life: Kai Gait, Senior Global Digital Director at GlaxoSmithKline
December 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, GSK, Interview, UK, US, digital, senior global director, technology
Kai Gait, Senior Global Digital Director at GlaxoSmithKline, retraces the steps that have led him to where he is today, …
GSK to acquire oncology biotech Tesaro for $5.1 billion
December 3, 2018Sales and Marketing GSK, GlaxoSmtihKline, Tesaro, acquisition, oncology, pharma
GlaxoSmithKline is set to acquire US-based oncology biotech Tesaro after both companies signed a definitive agreement with an aggregate cash …
GSK retain top spot on access to medicines list
November 22, 2018Business Services, Research and Development GSK, J&J, JJ, R&D, Sanofi, access, low and middle income countries, researh
The majority (63%) of research and development projects are being conducted by just five companies; GSK, Johnson & Johnson, Sanofi, …
GSK veteran Dave Tudor joins MMIC in Scotland
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing
GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
Top Ten most popular articles on Pharmafile.com this week!
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines
The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
GSK’s anti-seizure drug shows promise in early depression study
November 2, 2018Medical Communications, Research and Development GSK, GlaxoSmithKline, Potiga, depression, pharma
Researchers have found that GlaxoSmithKline’s ezogabine (Potiga), approved by the FDA in 2011 as an anti-seizure therapy, could have applications …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
